The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GTX, ZSAN and TILE
NEW YORK, NY / ACCESSWIRE / November 23, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Garrett Motion Inc. (NYSE:GTX)
Class Period: October 1, 2018 - September 18, 2020
Lead Plaintiff Deadline: November 24, 2020
The GTX lawsuit alleges Garrett Motion Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (1) due to its agreement to indemnify and reimburse Honeywell for certain asbestos-related liability, Garrett was saddled with an unsustainable level of debt; (2) as a result, Garrett had a highly leveraged capital structure that posed significant challenges to its overall strategic and financial flexibility; (3) as a result of the foregoing, Garrett's ability to gain or hold market share was impaired; (4) as a result of the foregoing, the Company was reasonably likely to seek bankruptcy protection; and (5) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Learn about your recoverable losses in GTX: http://www.kleinstocklaw.com/pslra-1/garrett-motion-inc-loss-submission-form?id=11163&from=1
Zosano Pharma Corporation (NASDAQ:ZSAN)
Class Period: February 13, 2017 - September 30, 2020
Lead Plaintiff Deadline: December 28, 2020
Throughout the class period, Zosano Pharma Corporation allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's clinical results reflected differences in zolmitriptan exposures observed between subjects receiving different lots; (2) pharmocokinetic studies submitted in connection with the Company's New Drug Application included patients exhibiting unexpected high plasma concentrations of zolmitriptan; (3) as a result of the foregoing differences among patient results, the U.S. Food and Drug Administration was reasonably likely to require further studies to support regulatory approval of the Company's lead product candidate, Qtrypta; (4) as a result, regulatory approval of Qtrypta was reasonably likely to be delayed; and (5) as a result of the foregoing, Defendants' public statements were materially false and misleading at all relevant times.
Learn about your recoverable losses in ZSAN: http://www.kleinstocklaw.com/pslra-1/zosano-pharma-corporation-loss-submission-form?id=11163&from=1
Interface, Inc. (NASDAQ:TILE)
Class Period: March 2, 2018 - September 28, 2020
Lead Plaintiff Deadline: January 11, 2021
The TILE lawsuit alleges Interface, Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (i) Interface had inadequate disclosure controls and procedures and internal control over financial reporting; (ii) consequently, Interface, inter alia, reported artificially inflated income and earnings per share ("EPS") in 2015 and 2016; (iii) Interface and certain of its employees were under investigation by the SEC with respect to the foregoing issues since at least as early as November 2017, had impeded the SEC's investigation, and downplayed the true scope of the Company's wrongdoing and liability with respect to the SEC investigation; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.
Learn about your recoverable losses in TILE: http://www.kleinstocklaw.com/pslra-1/interface-inc-loss-submission-form?id=11163&from=1
Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
View source version on accesswire.com:
© 2020 Accesswire. All Rights Reserved.